Minerva Neurosciences, Inc

In the quarter to June 2026, EPS grew 183.7% and free cash flow fell 553.5%, each against the same quarter a year earlier.

2.35 0.07 −2.89%

Follow NERV

Alert me

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	49.88%	352.58%	293.17%	322.05%
ROA Full definition →		(39.57%)	(434.34%)	(654.56%)	(629.71%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(135.54%)	(363.11%)	(556.22%)	(521.51%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(1.88)	(1.60)	(0.34)	(0.56)
Free Cash Flow Full definition →		(14.20)	(13.51)	(14.87)	(26.17)
Other line items
Cash ROIC Full definition →		63.97%	23.16%	8.45%	18.97%
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		1.01	0.05	0.04	0.07
Depreciation/Fixed assets Full definition →		3.93	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.88)	(1.60)	(0.34)	(0.56)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Columns are period end dates